Established in 1967, GC Biopharma is a top ranked pharmaceutical company in South Korea, and an experienced world-leading exporter in 64 countries. With over 55 years of manufacturing experience in biopharma, GC Biopharma is dedicated to manufacturing Drug Products (DP) for vaccines (Sterile vials and PFS) and non-vaccine Fill Finish and Packaging. Our mission is to exceed customer expectation, to provide one-stop solution service, and to become an accessible & credible partner. GC Biopharma provides the contract manufacturing (CMO) Drug Products service with 100% certified cold chain logistic system. We have three state-of-the-art fill-finish facilities located in South Korea. One of the plant is the largest vaccine manufacturing base in South Korea with WHO PQ approval. How to contact us : Location: Yongin-si, Gyeonggi-do, Republic of Korea Email: [email protected] Tel: +82 43 906 1940
我们正在追踪 GC Biopharma CDMO & Ochang Plant 的市场扩张
GC Biopharma CDMO & Ochang Plant 的国际扩张与竞争对手的对比情况
GC Biopharma CDMO & Ochang Plant你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 GC Biopharma CDMO & Ochang Plant你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
GC Biopharma 的 Hunterase 在亨特氏综合征的第三期试验中显示显著疗效，改善活动能力并降低 GAG 水平。
GC绿十字在ISTH 2025发表免疫球蛋白粘度研究，表明室温给药可能降低血栓风险。该研究比较了五种产品在不同温度下的粘度。
GC Biopharma 的 BARYTHRAX，首个重组炭疽疫苗，在二期临床试验中证明安全有效，结果发表于《疫苗》期刊。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 GC Biopharma CDMO & Ochang Plant 的业务、市场和增长信号的快速解答。
